Osiris Therapeutics (OSIR) Misses Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Research and development: 2.31M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Research and development: 2.31M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Osiris Therapeutics (NASDAQ: OSIR) reported Q4 EPS of $0.02, $0.03 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $19.5 million versus the consensus estimate of $18.53 million.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Byline Bancorp (BY) Tops Q1 EPS by 6c
- Seacoast Banking Corporation of Florida (SBCF) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
